Position in SABS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$452
+$217 QoQ
Shares Held
116
+241.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,906,213,149 across 370 Biotechnology names. SABS ranks #339 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in SABS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452 | 116 | Shares | Defined | 2026-08-13 | |
| 2023-12-31 | $235 | 343 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $216 | 343 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $6,309 | 9,000 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||